⌘K

Home/Filings/4/0001651844-19-000023

4//SEC Filing

Robinson James George 4

Accession 0001651844-19-000023

CIK 0001018735other

View on SEC.gov Company Profile

Filed

Jul 11, 8:00 PM ET

Accepted

Jul 12, 2:07 PM ET

Size

10.4 KB

Accession

0001651844-19-000023

Insider Transaction Report

Form 4

Period: 2019-07-10

NYMOX PHARMACEUTICAL CORPNYMX

Robinson James George

Director

Transactions

Purchase
Common Stock
2019-07-10$1.72/sh+600$1,033→ 3,510,284 total
Purchase
Common Stock
2019-07-10$1.73/sh+5,834$10,093→ 3,509,384 total
Purchase
Common Stock
2019-07-10$1.73/sh+166$287→ 3,510,450 total
Purchase
Common Stock
2019-07-10$1.73/sh+300$519→ 3,509,684 total
Purchase
Common Stock
2019-07-10$1.72/sh+100$172→ 3,510,550 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

NYMOX PHARMACEUTICAL CORP

CIK 0001018735

Entity typeother

Related Parties

1

filerCIK 0001651844

Filing Metadata

Form type: 4
Filed: Jul 11, 8:00 PM ET
Accepted: Jul 12, 2:07 PM ET
Size: 10.4 KB

View on SEC.gov